Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-25 @ 3:30 AM
Study NCT ID:
NCT02079805
Status:
COMPLETED
Last Update Posted:
2017-08-02
First Post:
2014-03-04
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
Sponsor:
Takeda
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
279/NRP-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None